Cargando…

Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression

BACKGROUND: Tumor metastasis is a frequent cause of treatment failure for cancer patients. A key feature of metastatic cancer cells is their invasive ability. Cysteine proteases contribute to invasive properties of many cancer cell types. To analyze the contribution of cysteine proteases to metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ervin, Heather, Cox, James L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156918/
https://www.ncbi.nlm.nih.gov/pubmed/15904519
http://dx.doi.org/10.1186/1475-2867-5-14
_version_ 1782124334429503488
author Ervin, Heather
Cox, James L
author_facet Ervin, Heather
Cox, James L
author_sort Ervin, Heather
collection PubMed
description BACKGROUND: Tumor metastasis is a frequent cause of treatment failure for cancer patients. A key feature of metastatic cancer cells is their invasive ability. Cysteine proteases contribute to invasive properties of many cancer cell types. To analyze the contribution of cysteine proteases to metastasis we have over-expressed in B16 melanoma cells the natural cysteine protease inhibitor, cystatin C. We measured in vitro invasion of cystatin over-expression clones with Boyden chamber type assays. Tail-vein injections of cells were used to compare lung tumor colonization. Subcutaneous tumor growth and tumor cell metastasis from primary tumors were also analyzed. Apoptosis of tumor cells was measured in lung tissues following melanoma cell injection. RESULTS: Results show the in vitro invasion of cystatin C over-expressing cells was dramatically inhibited. Lung tumor colonization was also reduced. Increased tumor cell apoptosis was found to be an important factor and may be related to the reduced tumor burden noted in this system of melanoma metastasis. CONCLUSION: Cysteine proteases therefore, may be a target for future anti-metastatic therapies.
format Text
id pubmed-1156918
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11569182005-06-22 Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression Ervin, Heather Cox, James L Cancer Cell Int Primary Research BACKGROUND: Tumor metastasis is a frequent cause of treatment failure for cancer patients. A key feature of metastatic cancer cells is their invasive ability. Cysteine proteases contribute to invasive properties of many cancer cell types. To analyze the contribution of cysteine proteases to metastasis we have over-expressed in B16 melanoma cells the natural cysteine protease inhibitor, cystatin C. We measured in vitro invasion of cystatin over-expression clones with Boyden chamber type assays. Tail-vein injections of cells were used to compare lung tumor colonization. Subcutaneous tumor growth and tumor cell metastasis from primary tumors were also analyzed. Apoptosis of tumor cells was measured in lung tissues following melanoma cell injection. RESULTS: Results show the in vitro invasion of cystatin C over-expressing cells was dramatically inhibited. Lung tumor colonization was also reduced. Increased tumor cell apoptosis was found to be an important factor and may be related to the reduced tumor burden noted in this system of melanoma metastasis. CONCLUSION: Cysteine proteases therefore, may be a target for future anti-metastatic therapies. BioMed Central 2005-05-17 /pmc/articles/PMC1156918/ /pubmed/15904519 http://dx.doi.org/10.1186/1475-2867-5-14 Text en Copyright © 2005 Ervin and Cox; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Primary Research
Ervin, Heather
Cox, James L
Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
title Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
title_full Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
title_fullStr Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
title_full_unstemmed Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
title_short Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
title_sort late stage inhibition of hematogenous melanoma metastasis by cystatin c over-expression
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156918/
https://www.ncbi.nlm.nih.gov/pubmed/15904519
http://dx.doi.org/10.1186/1475-2867-5-14
work_keys_str_mv AT ervinheather latestageinhibitionofhematogenousmelanomametastasisbycystatincoverexpression
AT coxjamesl latestageinhibitionofhematogenousmelanomametastasisbycystatincoverexpression